BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29238946)

  • 1. PAPP-A2 a new key regulator of growth.
    Banaszak-Ziemska M; Niedziela M
    Endokrynol Pol; 2017; 68(6):682-691. PubMed ID: 29238946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Modulators of the Growth Hormone - Insulin-Like Growth Factor Axis: Pregnancy-Associated Plasma Protein-A2 and Stanniocalcin-2.
    Fujimoto M; Hwa V; Dauber A
    J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):1-8. PubMed ID: 29280739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disorders caused by genetic defects associated with GH-dependent genes: PAPPA2 defects.
    Fujimoto M; Andrew M; Dauber A
    Mol Cell Endocrinol; 2020 Dec; 518():110967. PubMed ID: 32739295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy-Associated Plasma Protein (PAPP)-A2 in Physiology and Disease.
    Barrios V; Chowen JA; Martín-Rivada Á; Guerra-Cantera S; Pozo J; Yakar S; Rosenfeld RG; Pérez-Jurado LA; Suárez J; Argente J
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-based differences in growth-related IGF1 signaling in response to PAPP-A2 deficiency: comparative effects of rhGH, rhIGF1 and rhPAPP-A2 treatments.
    Fernández-Arjona MDM; Navarro JA; López-Gambero AJ; de Ceglia M; Rodríguez M; Rubio L; Rodríguez de Fonseca F; Barrios V; Chowen JA; Argente J; Rivera P; Suárez J
    Biol Sex Differ; 2024 Apr; 15(1):34. PubMed ID: 38589872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short stature with low insulin-like growth factor 1 availability due to pregnancy-associated plasma protein A2 deficiency in a Saudi family.
    Babiker A; Al Noaim K; Al Swaid A; Alfadhel M; Deeb A; Martín-Rivada Á; Barrios V; Pérez-Jurado LA; Alfares A; Al Alwan I; Argente J
    Clin Genet; 2021 Nov; 100(5):601-606. PubMed ID: 34272725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability.
    Dauber A; Muñoz-Calvo MT; Barrios V; Domené HM; Kloverpris S; Serra-Juhé C; Desikan V; Pozo J; Muzumdar R; Martos-Moreno GÁ; Hawkins F; Jasper HG; Conover CA; Frystyk J; Yakar S; Hwa V; Chowen JA; Oxvig C; Rosenfeld RG; Pérez-Jurado LA; Argente J
    EMBO Mol Med; 2016 Apr; 8(4):363-74. PubMed ID: 26902202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy-associated plasma proteins and Stanniocalcin-2 - Novel players controlling IGF-I physiology.
    Frystyk J; Teran E; Gude MF; Bjerre M; Hjortebjerg R
    Growth Horm IGF Res; 2020; 53-54():101330. PubMed ID: 32693362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment With Recombinant Human Insulin-Like Growth Factor-1 Improves Growth in Patients With PAPP-A2 Deficiency.
    Muñoz-Calvo MT; Barrios V; Pozo J; Chowen JA; Martos-Moreno GÁ; Hawkins F; Dauber A; Domené HM; Yakar S; Rosenfeld RG; Pérez-Jurado LA; Oxvig C; Frystyk J; Argente J
    J Clin Endocrinol Metab; 2016 Nov; 101(11):3879-3883. PubMed ID: 27648969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter to the Editor: History and clinical implications of PAPP-A2 in human growth: When reflecting on idiopathic short stature leads to a specific and new diagnosis: Understanding the concept of "low IGF-I availability".
    Argente J; Pérez-Jurado LA
    Growth Horm IGF Res; 2018 Jun; 40():17-19. PubMed ID: 29653372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One level up: abnormal proteolytic regulation of IGF activity plays a role in human pathophysiology.
    Argente J; Chowen JA; Pérez-Jurado LA; Frystyk J; Oxvig C
    EMBO Mol Med; 2017 Oct; 9(10):1338-1345. PubMed ID: 28801361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal expression of Pappa2 gene may indirectly affect mouse hip development through the IGF signaling pathway.
    Chen Y; Li L; Wang E; Zhang L; Zhao Q
    Endocrine; 2019 Aug; 65(2):440-450. PubMed ID: 31168749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAPP-A2 expression by osteoblasts is required for normal postnatal growth in mice.
    Amiri N; Christians JK
    Growth Horm IGF Res; 2015 Dec; 25(6):274-80. PubMed ID: 26385171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papp-a2 modulates development of cranial cartilage and angiogenesis in zebrafish embryos.
    Kjaer-Sorensen K; Engholm DH; Jepsen MR; Morch MG; Weyer K; Hefting LL; Skov LL; Laursen LS; Oxvig C
    J Cell Sci; 2014 Dec; 127(Pt 23):5027-37. PubMed ID: 25236600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients.
    Nishizawa H; Pryor-Koishi K; Suzuki M; Kato T; Kogo H; Sekiya T; Kurahashi H; Udagawa Y
    Mol Hum Reprod; 2008 Oct; 14(10):595-602. PubMed ID: 18805800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of pregnancy-associated plasma protein-A2 in insulin-like growth factor (IGF) binding protein-5 proteolysis during pregnancy: a potential mechanism for increasing IGF bioavailability.
    Yan X; Baxter RC; Firth SM
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1412-20. PubMed ID: 20103653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic disorders in the growth hormone - insulin-like growth factor-I axis.
    Walenkamp MJ; Wit JM
    Horm Res; 2006; 66(5):221-30. PubMed ID: 16917171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphisms in the growth hormone-insulin-like growth factor axis in straightbred and crossbred Angus, Brahman, and Romosinuano heifers: population genetic analyses and association of genotypes with reproductive phenotypes.
    Luna-Nevarez P; Rincon G; Medrano JF; Riley DG; Chase CC; Coleman SW; Vanleeuwen DM; DeAtley KL; Islas-Trejo A; Silver GA; Thomas MG
    J Anim Sci; 2011 Apr; 89(4):926-34. PubMed ID: 21183713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy-associated plasma protein-A2 (PAPP-A2): tissue expression and biological consequences of gene knockout in mice.
    Conover CA; Boldt HB; Bale LK; Clifton KB; Grell JA; Mader JR; Mason EJ; Powell DR
    Endocrinology; 2011 Jul; 152(7):2837-44. PubMed ID: 21586553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomics changes in patients with PAPP-A2 deficiency in response to rhIGF1 treatment.
    Mastrangelo A; Martos-Moreno GÁ; Rupérez FJ; Chowen JA; Barbas C; Argente J
    Growth Horm IGF Res; 2018; 42-43():28-31. PubMed ID: 30119035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.